Lawrence H. Schwartz

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

J Shapero, L H Schwartz, L Schwartz, L. H. Schwartz, L. Schwartz, L.H. Schwartz, LARRY SCHWARTZ, Larry H. Schwartz, Larry Schwartz, Lawrence H. Schwartz

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Irving Medical Center Cornell University Institut Gustave Roussy NewYork–Presbyterian Hospital

About

Lawrence H. Schwartz is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	891
2	Health Sciences	5	5	434
3	Immunology	4	4	453
4	Engineering	2	2	114
5	Nephrology	1	1	231

Lawrence H. Schwartz

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of lymph nodes with RECIST 1.1 Lawrence H. Schwartz, Jan Bogaerts, Robert Ford, European Journal of Cancer Medical ImagingMedicineRecist 1.1HistopathologyLymphatic System	2008	288
Prevalence and Importance of Small Hepatic Lesions Found at CT in Patients with Cancer Lawrence H. Schwartz, Eric J. Gandras, Sandra Colangelo, Radiology	1999	255
Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Robert J. Motzer, Ashok Rakhit, Lawrence H. Schwartz, PubMed ImmunologyImmunoeditingPharmacotherapyMetronomic ChemotherapyImmunotherapy	1998	231
Renal Masses: Characterization with Diffusion-weighted MR Imaging—A Preliminary Experience Jingbo Zhang, Yousef Mazaheri Tehrani, Liang Wang, Radiology	2008	212
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. Robert J. Motzer, Dean F. Bajorin, Lawrence H. Schwartz, Journal of Clinical Oncology	1994	174
When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression Geoffrey R. Oxnard, Michael J. Morris, F. Stephen Hodi, JNCI Journal of the National Cancer Institute	2012	125
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics Romain‐David Seban, John S. Nemer, Aurélien Marabelle, European Journal of Nuclear Medicine and Molecular Imaging Cancer ImmunosurveillanceAnti-pd1 ImmunotherapyMedicineBiomarker TargetMelanoma	2019	123
Hepatocellular Carcinoma: MR Imaging Findings in Cirrhotic Livers and Noncirrhotic Livers Corinne Winston, Lawrence H. Schwartz, Yuman Fong, Radiology	1999	96
Deep learning for the prediction of early on-treatment response in metastatic colorectal cancer from serial medical imaging Lin Lü, Laurent Dercle, Binsheng Zhao, Nature Communications	2021	96
Eye Tracking for Deep Learning Segmentation Using Convolutional Neural Networks Joseph N. Stember, Haydar Çelik, Elizabeth A. Krupinski, Journal of Digital Imaging Convolutional Neural NetworkMedical Image SegmentationEngineeringMachine LearningSegmentation Masks	2019	73

Page 1